Olav Dalgård
Impact in
- Hepatology top 0.1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
Papers in
- Hepatology 87
- Hepatitis C virus research 86
- Liver Disease and Transplantation 3
- Epidemiology 78
- Liver Disease Diagnosis and Treatment 59
- Hepatitis B Virus Studies 56
- HIV, Drug Use, Sexual Risk 12
- Co-authors
- Alessio Aghemo (4 shared papers)Massimo Puoti (2 shared papers)Jean–Michel Pawlotsky (2 shared papers)Heiner Wedemeyer (2 shared papers)Francesco Negro (2 shared papers)Geoffrey Dusheiko (2 shared papers)Marina Berenguer (2 shared papers)Kjell Skaug (9 shared papers)
In The Last Decade
Olav Dalgård
87 papers receiving 4.8k citations
Olav Dalgård's Hit Papers
Peers
Comparison fields: 5 of 116
- Hepatology 4.3k
- Epidemiology 4.1k
- Infectious Diseases 723
- Immunology 336
- Virology 72
Countries citing papers authored by Olav Dalgård
This map shows the geographic impact of Olav Dalgård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav Dalgård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav Dalgård more than expected).
Fields of papers citing papers by Olav Dalgård
This network shows the impact of papers produced by Olav Dalgård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav Dalgård. The network helps show where Olav Dalgård may publish in the future.
Co-authors
The 25 scholars most cited alongside Olav Dalgård, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EASL Recommendations on Treatment of Hepatitis C 2018 Hit paper breakdown → | 2018 | 1487 |
| 2 | EASL recommendations on treatment of hepatitis C: Final update of the series☆ Hit paper breakdown → | 2020 | 707 |
| 3 | 2004 | 240 | |
| 4 | 2011 | 230 | |
| 5 | 2015 | 135 | |
| 6 | 2007 | 135 | |
| 7 | 2016 | 125 | |
| 8 | 2019 | 114 | |
| 9 | 2011 | 112 | |
| 10 | 2011 | 111 | |
| 11 | 2002 | 110 | |
| 12 | 2016 | 104 | |
| 13 | 2013 | 86 | |
| 14 | 2018 | 83 | |
| 15 | 2013 | 82 | |
| 16 | 2002 | 80 | |
| 17 | 2004 | 75 | |
| 18 | 2005 | 72 | |
| 19 | 2003 | 60 | |
| 20 | 2020 | 54 |
About Olav Dalgård
Olav Dalgård is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Pathology and Forensic Medicine and Rheumatology, having authored 95 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (86 papers), Liver Disease Diagnosis and Treatment (59 papers), Hepatitis B Virus Studies (56 papers), HIV, Drug Use, Sexual Risk (12 papers), Alcohol Consumption and Health Effects (5 papers), HIV/AIDS drug development and treatment (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Hepatology (4.3k citations), Epidemiology (4.1k citations), Infectious Diseases (723 citations), Immunology (336 citations) and Virology (72 citations). Olav Dalgård has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Alessio Aghemo, Massimo Puoti, Jean–Michel Pawlotsky, Heiner Wedemeyer, Francesco Negro, Geoffrey Dusheiko, Marina Berenguer, Kjell Skaug, Kristian Bjøro and Kjell B. Hellum. Their work appears in journals such as Journal of Hepatology, International Journal of Drug Policy, Hepatology, PLoS ONE and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.